SEC 13F Intelligence

Highvista Strategies LLC / COGT

Highvista Strategies LLC’s Cogent Biosciences Inc Position

Does Highvista Strategies LLC own Cogent Biosciences Inc (COGT)? Yes197.1K shares worth $8M (+2.09% of its 13F portfolio) as of Q1 2026, down from 336.7K shares the prior filed quarter.

Position Value
$8M
Q1 2026
Shares
197.1K
% of Portfolio
+2.09%
Quarters Held
15
currently held

Position History COGT

Reported value by quarter
Q3 ’22: $2MQ3 ’22Q4 ’22: $2MQ1 ’23: $2MQ1 ’23Q2 ’23: $3MQ3 ’23: $2MQ3 ’23Q4 ’23: $2MQ1 ’24: $2MQ1 ’24Q2 ’24: $2MQ3 ’24: $2MQ3 ’24Q4 ’24: $2MQ1 ’25: $2MQ1 ’25Q2 ’25: $2MQ3 ’25: $7MQ3 ’25Q4 ’25: $12MQ1 ’26: $8MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026197.1K$8M+2.09%
Q4 2025336.7K$12M+3.08%
Q3 2025462.4K$7M+1.63%
Q2 2025283.2K$2M+0.75%
Q1 2025279.7K$2M+0.65%
Q4 2024279.7K$2M+0.81%
Q3 2024225.6K$2M+0.84%
Q2 2024281.1K$2M+0.87%
Q1 2024281.1K$2M+0.67%
Q4 2023281.1K$2M+0.60%
Q3 2023198.6K$2M+0.90%
Q2 2023216.1K$3M+1.17%
Q1 2023184.0K$2M+1.62%
Q4 2022184.0K$2M+1.26%
Q3 2022118.9K$2M+1.01%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highvista Strategies LLC’s full portfolio or all institutional holders of COGT.